Can vitamin D supplementation improve treatment outcomes in patients subjected to anti-cancer immunotherapy?
Written By : Dr. Kamal Kant Kohli
Published On 2023-07-28 14:30 GMT | Update On 2023-07-28 14:31 GMT
Advertisement
Poland: A recent study has suggested that maintaining normal vitamin D levels while receiving immunotherapy medications called immune checkpoint inhibitors may be important for patients with advanced skin cancer and should be considered a standard procedure to improve treatment outcomes.
The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
Vitamin D has many effects on the body, including immune system regulation. To see whether vitamin D levels might impact the effectiveness of immune checkpoint inhibitors, investigators analyzed the blood of 200 patients with advanced melanoma before and every 12 weeks during immunotherapy treatment.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.